The human embryonic stem cell line NYSCFe001-A was derived from a day 6 blastocyst in feeder-free and antibiotic free conditions. The blastocyst was voluntarily donated for research as surplus after in vitro fertilization treatment following informed consent. The NYSCFe001-A line, registered as NYSCF100 on the NIH registry, presents normal karyotype, is mycoplasma free, expresses all the pluripotency markers and has the potential to differentiate into all three germ layers in vitro.
Pubmed ID: 29631040 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets Actin, α-Smooth Muscle
View all literature mentionsThis monoclonal targets Neuronal Class III beta-Tubulin (TUJ1) Purified
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentionsThis monoclonal targets Mouse IgG3 k Isotype Control Alexa Fluor 647 Clone J606
View all literature mentionsThis monoclonal targets IgM
View all literature mentionsThis unknown targets TRA-1-60 Antigen
View all literature mentionsThis monoclonal targets Human TRA-1-60
View all literature mentionsThis monoclonal targets Human TRA-1-81 Affinity Purified
View all literature mentionsThis monoclonal targets SSEA4 antibody [MC813] - Embryonic Stem Cell Marker
View all literature mentionsThis monoclonal targets Sox2
View all literature mentionsThis monoclonal targets Nanog
View all literature mentionsThis monoclonal targets Pou5f1
View all literature mentions